1. The present study used functional and electrophysiological approaches to investigate the mechanisms by which warifteine, a bisbenzylisoquinoline alkaloid isolated from Cissampelos sympodialis Eichl., causes vasorelaxation of the rat thoracic aorta.
INTRODUCTION
Hypertension is a global public health concern that is universally accepted as an important prognostic factor for cardiovascular diseases and premature mortality. Therefore, the prevention and treatment of hypertension remain a priority for the medical community. 1 Substances derived from natural products are an important source of new medicines. Alkaloids constitute the largest class of botanical secondary metabolites, exhibiting therapeutic effects, such as antirheumatic, 2 antihyperglycaemic, 3 antiviral 4 and antiinflammatory actions. 4, 5 From this group of naturally occurring organic compounds, the bisbenzylisoquinoline alkaloids (e.g. cycleanine, tetrandine and berbamine) exhibit diverse biological activities, such as suppression of hepatic injury and the production of tumour necrosis factor in Bacille Calmette-Guerin plus lipopolysaccharide-treated mice. 6, 7 In addition to its antihypertensive effect on spontaneously hypertensive rats, renal hypertensive rats and deoxycorticosterone acetate-salt hypertensive rats, 8 tetrandine has been shown to decrease systolic and diastolic arterial pressure in humans. 9 Dauricine and daurisoline have been shown to have anti-arrhythmic actions, 10 providing further evidence of the beneficial cardiovascular effects of bisbenzylisoquinoline alkaloids. Therefore, further studies into this chemical structure may result in new treatments for cardiovascular problems, such as arrhythmia and hypertension.
Cissampelos sympodialis Eichl. (Menispermaceae), a species found in north-eastern and south-eastern Brazil, has been used in folk medicine for the treatment of rheumatism, colds, asthma and other conditions. 11 Phytochemical analyses of the roots of this plant revealed the presence of a group of alkaloids, namely warifteine, methylwarifteine, roraimine and milonine. Warifteine (C 36 H 36 N 2 O 6 ; molecular weight 592.7; Fig. 1 ), a bisbenzylisoquinoline alkaloid, 12 is the predominant component isolated from the ethanolic extract of C. sympodialis root bark. Several studies have shown promising pharmacological effects of C. sympodialis and warifteine on biological systems, including immunomodulation, 13 antidepressant effects 14 and inhibition of eosinophil recruitment. 11 However, few reports have investigated the effects of warifteine on vasomotor tone, despite the known antiarrhythmic and antihypertensive properties of compounds from the same chemical class as warifteine. Previous studies have demonstrated that warifteine induces concentration-dependent relaxation of the rabbit aorta. 12 This relaxation was shown to be due to inhibition of voltage-dependent Ca 2+ channels (VDCC), receptor-operated Ca 2+ channels and Ca 2+ liberation from noradrenaline-sensitive intracellular stores in the rabbit aorta. 12 However, the mechanism underlying warifteine-induced relaxation of the vascular smooth muscle remains unclear. In the present study, the vasorelaxant effects of warifteine were examined in the rat aorta using combined functional and electrophysiological approaches.
METHODS Animals
This study was performed in accordance with the Guide for the Care and Use of Laboratory Animals as adopted by the US National Institutes of Health (http://oacu.od.nih.gov/regs/guide/ guide_2011.pdf, accessed November 2011) and was approved by the Animal Care and Use Committees of the Federal University of Paraíba and the Federal University of Minas Gerais. Male Wistar rats (250-300 g) were used for all experiments. Rats were housed under temperature-controlled (21 AE 1°C) conditions and a 12 h light-dark cycle (lights on 0600-1800 h). In addition, rats had free access to food (PURINA-Brazil, Canoas, Brazil) and tap water.
Preparation of thoracic aortic rings
Rats were killed in a CO 2 gas chamber and the thoracic aorta was isolated and placed in Krebs' solution (composition (in mmol/L): NaCl 118; KCl 4.7; NaHCO 3 25; CaCl 2 2.5; glucose 11.1; KH 2 PO 4 1.2; MgSO 4 1.2). Fat and connective tissues were removed carefully and the aorta was cut into 2-4 mm rings. The endothelium was removed mechanically when necessary by gently rubbing the intimal surface with a metal rod. The aortic rings were suspended horizontally between two stainless steel wires in organ baths containing Krebs' solution, maintained at 37°C and gassed with 95% O 2 and 5% CO 2 . Isometric tension was recorded with a force-displacement transducer (FORT-10; World Precision Instruments (WPI), Sarasota, FL, USA) coupled to an amplifier-recorder (Transbridge-4; WPI). Rings were stabilized under a resting tension of 2 g for 1 h. The presence of functional endothelium was assessed by the ability of acetylcholine (1 lmol/L) to induce relaxation of at least 80% in vessels precontracted with phenylephrine (1 lmol/L). The absence of acetylcholine-mediated relaxation in vessel segments was indicative of a functionally denuded endothelium.
Vasorelaxant effects of warifteine in precontracted aortic rings
The first series of experiments examined the effects of warifteine on sustained contractions induced by noradrenaline (10-100 lmol/L).
After the equilibration period, aortic rings, with or without functional endothelium, were precontracted with the agonist. Once a plateau had been attained, cumulative concentration-dependent relaxation curves were constructed to warifteine (1 pmol/L-10 lmol/L). Experiments were also performed in endotheliumdenuded mesenteric rings precontracted with prostaglandin (PG) F 2a (1-10 mmol/L) or high K + (80 mmol/L) to further explore the mechanisms underlying warifteine-induced vasorelaxation. Control experiments conducted in the absence of warifteine were performed to monitor the stability of the noradrenaline-, PGF 2a -or high K + -induced contractions. In each experiment, a concentrationresponse curve was constructed to the contractile agent to enable rings to be contracted to the same degree. High-K + Krebs' solution were prepared by replacing NaCl with an equivalent amount of KCl to maintain osmolarity.
Role of K + channels in warifteine-induced vasorelaxation
The vasorelaxant effects of warifteine were examined in endothelium-denuded rat aortic rings exposed to Krebs' solution containing increasing concentrations of K + (from 4.7 to 20 mmol/L) to investigate whether the warifteine-induced relaxation was due to potassium channel activation. Increasing external K + concentrations decreases K + efflux and prevents relaxation mediated by the opening of K + channels. To investigate which K + channels were involved in the vasorelaxant responses to warifteine, endotheliumdenuded aortic rings were pretreated for 30 min with tetraethylammonium (TEA; 1, 3 and 5 mmol/L), iberiotoxin (20 nmol/L), 4-aminopyridine (1 mmol/L), barium (1 mmol/L) or glibenclamide (10 lmmol/L) prior to being precontracted with noradrenaline (10-100 lmol/L). Shortly after its addition, TEA produced a slight change in arterial basal tone (from 1.70 AE 0.12 to 2.41 AE 0.22 g). However, in all our experiments, only arterial rings that demonstrated the same magnitude of contraction were used. Cumulative concentration-response curves were then constructed and compared with those obtained in vessels that had not been pretreated with the K + channel blockers.
Effects of warifteine on Ca 2+ -induced contractions
To further examine the effects of warifteine on Ca 2+ influx through the plasma membrane, two sets of experiments were performed in endothelium-denuded aortic rings. In the first set of experiments, extracellular Ca 2+ was removed by washing the vessels with Ca 2+ -free Krebs' solution, which had the same composition as Krebs' solution but without CaCl 2 and with the addition of 1 mmol/L EGTA, followed by a series of additions of noradrenaline (100 lmol/L) to deplete intracellular Ca 2+ stores. After the depletion of intracellular Ca 2+ stores, as confirmed by the loss of contractile responses to noradrenaline, the rings were maintained in Ca 2+ -free Krebs' solution. Following a 10 min equilibration period, vascular contractions were initiated by the addition of CaCl 2 (2 mmol/L) to the organ baths, either the absence (control) or the presence of warifteine (10 lmol/L, 15 min).
In the second set of experiments, CaCl 2 -induced contractions were investigated in rings stabilized in high-
nominally Ca 2+ -free, Krebs' solution (Krebs' solution without CaCl 2 and no EGTA added). Contractions were induced by the 
Isolation of vascular myocytes
Vascular myocytes were isolated enzymatically from rat aorta using a procedure similar to that reported previously. 15 Briefly, small pieces of endothelium-free rat aorta were placed in a physiological solution (PS; composition (in mmol/L): NaCl 137; KCl 5.6; MgCl 2 1; CaCl 2 2.6; NaHCO 3 4.17; NaH 2 PO 4 0.44; Na 2 HPO 4 0.42; glucose 5; HEPES 10) containing 0.7 mg/mL papain (Sigma-Aldrich, St Louis, MO, USA), 1 mg/mL albumin (Sigma-Aldrich) and 1 mg/mL dithiothreitol (Sigma-Aldrich), and were incubated at 37°C for 30 min. After 30 min in the enzymatic solution, the pieces of tissue were removed, washed in enzyme-free physiological solution and exposed to a low-Ca 2+ PS (the same composition as the PS, except with 0.05 mmol/L CaCl 2 and 3.55 mmol/L MgCl 2 ) containing 1 mg/mL collagenase, 0.9 mg/mL hyaluronidase (Sigma, St Louis, MO, USA) and 1 mg/mL albumin (Sigma). Single cells were obtained by gentle titration with a Pasteur pipette. Aliquots of single cell suspensions were then placed in experimental chambers for electrophysiological recordings. All experiments were performed on the day of isolation.
Electrophysiological recordings
Potassium currents were recorded using the whole-cell, patchclamp configuration 16 at room temperature (23-25°C). Borosilicate glass pipettes were pulled from glass capillaries (Perfecta, São Paulo, Brazil) using a micropipette puller (PP-830; Narishige, Tokyo, Japan). Pipettes were filled with K + -based pipette solution (composition (in mmol/L): KCl 130; NaCl 5; EGTA 5; HEPES 5, pH adjusted to 7.4 with KOH) and carried resistances between 2 and 4 MΩ. An Ag-AgCl wire was used as the reference electrode. The composition of the external solution was (in mmol/L): NaCl 137; KCl 5.6; MgCl 2 1; CaCl 2 2.6; NaHCO 3 4.17; NaH 2 PO 4 0.44; Na 2 HPO 4 0.42; glucose 5; HEPES 10 (pH adjusted to 7.4 with NaOH). This solution was gravity delivered, controlled by solenoid valves. Data were acquired using EPC-9 patch clamp amplifiers and 'Pulse' acquisition software (HEKA Electronik, Lambrecht, Germany), low-pass filtered at 3 kHz and sampled at 10 kHz. Cancellation of the capacity transients and leak subtraction were performed using a programmed P/4 protocol. 17 Cells with a visible changes in leakage currents throughout the study were discarded. The cell membrane capacitance was 11.50 AE 0.14 pF (n = 24). Families of the macroscopic K + currents were generated stepwise by 10 mV depolarizing pulses (pulse duration 200 msec; holding potential À40 mV) from À50 to À70 mV. Current amplitude was recorded before (control) and during (treatment) the application of a drug.
Chemicals
Noradrenaline, PGF 2a , phenylephrine, acetylcholine, EGTA, albumin, 4-aminopyridine, glibenclamide, hyaluronidase Type II, papain, DL-dithiothreitol, TEA, cremophor and dimethyl sulphoxide were purchased from Sigma-Aldrich. Collagenase Type II (CLS2) was purchased from Worthington Corporation (Freehold, NJ, USA). Warifteine was solubilized in a mixture of 50 lL cremophor/1000 lL water and diluted to the desired concentration just before use. The final concentration of cremophor in the tissue bath never exceeded 0.01%. At that concentration, L-cremophor did not have any measurable effects in our experiments (data not shown).
Curve fitting and statistics
Data are presented as the mean AE SEM of n rings prepared from different rats. Concentration-response curves to warifteine were based on the percentage relaxation of agonist-induced contractions. A value of 100% relaxation was assigned when the precontracted rings returned to baseline tension. Curves were fitted using a variable slope sigmoid fitting routine in Prism4 (GraphPad, San Diego, CA, USA). The pEC 50 (negative log of the concentration required to produce 50% relaxation) and E max (maximum percentage relaxation) values were calculated from the fitted sigmoidal curves. Statistical analyses were performed to compare E max and pEC 50 values between groups of independent observations. Unpaired or paired Student's t-test or oneway ANOVA were used to compare two, three or more groups, respectively, followed by Bonferroni's multiple comparisons post-test with correction to avoid the risk of Type 1 and Type 2 errors. These corrections were performed to gain better protection against a-level inflation due to multiple tests of significance. Thus, for our data, the overall a-level (0.05) was divided among the number of tests of significance tested. The new a-level used in the equation was a = (desired for entire study/ no. significance tests done). Two-sided P < 0.05 was considered significant. Electrophysiological data were analysed using the 'Pulse-Fit' analysis program (HEKA Elektronik) and SigmaPlot (SPSS, Chicago, IL, USA). Current-voltage relationships were calculated on the basis of the peak values (leakage corrected) from the original currents.
RESULTS
Relaxant effects of warifteine in rat thoracic aorta Figure 2a shows warifteine-mediated relaxation responses in rat aortic rings. Cumulative addition of warifteine (1 pmol/L-10 lmol/L) resulted in concentration-dependent vasorelaxation of endothelium-intact rings precontracted with noradrenaline (10-100 lmol/L; pD 2 = 9.40 AE 0.06; E max = 97.3 AE 1.2%; n = 5). Removal of the endothelium had no significant effect on the pD 2 or E max of warifteine-induced relaxations (pD 2 = 9.20 AE 0.10; E max = 88.41 AE 3.83%; n = 5; P > 0.05 compared with endothelium-intact rings, unpaired Student's t-test; Fig. 2b ; Table 1 ). However, the vasorelaxant effects of two concentrations of warifteine (10 À9 and 10 À8 mol/L) differed significantly between endothelium-intact and -denuded rings (P < 0.05 and P < 0.01, respectively, unpaired Student's t-test). These results suggest that warifteine predominantly acts on arterial smooth muscle. Because there were no significant differences observed in pD 2 or E max values for warifteine-induced relaxations in endothelium-intact and -denuded rings, all subseqnent experiments were performed in endothelium-denuded rings. The time required for maximal responses to each concentration of warifteine to be reached ranged from 10 to 15 min. A series of experiments was designed to determine whether warifteine was competing with noradrenaline to induce relaxation via blockade of adrenoceptors. In one set of experiments, blood vessels were precontracted via PGF 2a (1-10 mmol/L)-mediated stimulation of prostanoid FP receptors. In another set of experiments, arteries were precontracted by high-K + (80 mmol/L). As indicated in Fig. 2c and Table 1 , the inhibitory effects of warifteine were not limited to noradrenaline-induced contractions because warifteine also induced concentration-dependent relaxation of PGF 2a -precontracted rings (pD 2 = 9.20 AE 0.19; n = 8), although the E max was significantly attenuated (64.40 AE 4.50%; n = 8; P < 0.01, ANOVA with Bonferroni's multiple comparisons post-test) when compared with that in noradrenaline-precontracted rings. In contrast, the relaxant activity of warifteine was nearly abolished in high-K + (80 mmol/L)-precontracted aortic rings (E max = 13.95 AE 2.87%; n = 6; P < 0.01, ANOVA with Bonferroni's multiple comparisons post-test).
Role of K + channels in warifteine-induced vasorelaxant response
Based on the observation that the relaxant activity of warifteine was abolished in high-K + (80 mmol/L)-precontracted aortic rings, subsequent experiments were performed to investigate the role of K + channels in warifteine-mediated relaxation. As indicated in Fig. 3a 23 ). As indicated in Fig. 3b and Table 1 , when aortic rings were incubated with 1, 3 and 5 mmol/L TEA, pD 2 and E max values to warifteine were significantly attenuated (ANOVA with Bonferroni's multiple comparisons post-test) compared with control. In addition, the relaxation induced by warifteine was strongly inhibited when aortic rings were exposed to iberiotoxin ( Fig. 3c ; Table 1 ). Glibenclamide had a significant effect on responses to warifteine only at a concentration of 10 À9 mol/L ( Fig. 3d ; Table 1 ), whereas Ba 2+ and 4-aminopyridine had no significant effect on warifteineinduced relaxation ( Fig. 3f ; Table 1 ). These observations indicate that warifteine elicits vasorelaxation by modulating K + channels, mostly BK Ca activation.
Warifteine increases K + current in vascular myocytes
The effects of warifteine on K + currents were examined using whole-cell voltage-clamp techniques in freshly dissociated vascular myocytes isolated from the rat aorta. Cells were depolarized from a holding potential of À40 mV to test potentials in the range À50 to 70 mV using 10 mV steps. Figure 4a shows representative traces obtained at 70 mV before and after exposure of cells to warifteine (100 nmol/L). The time required to achieve the maximum effect was approximately 10 s. Figure 4b summarizes the current-voltage relationship in the absence and presence of warifteine (100 nmol/L). Under these recording conditions Data are the mean AE SEM. *P < 0.05. and ***P < 0.001 compared with endothelium-denuded control (one-way ANOVA followed by Bonferroni's post test; 11 comparisons). (dialysed cells with a pipette solution containing 5 mmol/L EGTA), the addition of warifteine significantly (P < 0.05, paired Student's t-test) increased K + currents in the range 60-70 mV, demonstrating that warifteine is able to interfere with K + channels in single rat vascular myocytes.
Effects of warifteine on CaCl 2 -induced contractions
The ability of warifteine to directly influence Ca 2+ influx was evaluated by studying its effects on contractile responses to CaCl 2 in rat aortic rings that had been stimulated with either noradrenaline (100 lmol/L) or high K + (60 mmol/L) in the absence of extracellular Ca 2+ . Figure 5a shows the effects of warifteine (10 lmol/L) on CaCl 2 -induced contractions in noradrenaline (100 lmol/L)-stimulated rat aortic rings depleted of intracellular Ca 2+ . In these preparations, the addition of a single concentration of CaCl 2 (2 mmol/L) resulted in contraction of the aortic rings. Pre-incubation with warifteine (10 lmol/L) for 15 min had no significant effect on the responses to CaCl 2. When vessels were stimulated with high-K + (60 mmol/L) under nominally Ca 2+ -free conditions, the cumulative addition of CaCl 2 (from 1 lmol/L to 30 mmol/L) induced concentration-dependent contractions. Warifteine (10 lmol/L) had no effect on concentration-response curves to CaCl 2 (Fig. 5b) , indicating that direct inhibition of Ca 2+ influx is not likely to be involved in warifteine-induced relaxation of rat aortic rings.
DISCUSSION
The present study demonstrates possible mechanisms by which warifteine causes vasorelaxation of the rat aorta. Our findings demonstrate that warifteine elicits a potent relaxation of the rat aorta and this response is likely mediated via the increased open probability of K + channels in the vascular smooth muscle.
The pharmacological actions of vasodilator compounds are due mainly to either a direct effect on vascular smooth muscle or an indirect effect mediated by the release of a relaxing factor(s) from endothelial cells. 24 The present study has shown that the vasodilator response to warifteine is not altered by mechanical removal of the endothelium, indicating that the actions of warifteine are due to a direct effect on vascular smooth muscle.
Warifteine-mediated vasodilatation was not limited to contractile responses evoked by a single vasoconstrictor. In the present study, warifteine effectively relaxed arteries that had been contracted by two different receptor-dependent constrictors, namely noradrenaline (an adrenoceptor agonist) and PGF 2a (a prostanoid FP receptor agonist), suggesting that warifteine may interfere with multiple receptor-mediated vasoconstrictor mechanisms. However, warifteine had a smaller effect on rings contracted with PGF 2a . In addition, warifteine had little effect on contractions induced by high K + (80 mmol/L). It is well-known that potassium-mediated smooth muscle contractions are initiated by membrane depolarization, resulting in an increase in Ca 2+ influx via voltage-gated (L-and T-type) Ca 2+ channels. 25, 26 The membrane depolarization results from increasing the extracellular K + concentration, which reduces the electrochemical gradient for K + efflux. The lack of effect of warifteine under these conditions strongly suggests that K + channel activation plays a predominant role in warifteine-mediated relaxation. This was further supported by the observation that the reduced K + efflux gradient (Krebs' solution containing 20 mmol/L KCl) largely inhibited the vasorelaxant effect of warifteine against noradrenaline-induced contractions in rat aortic rings. Several types of K + channels have been identified in vascular smooth muscle. The most abundant include BK Ca and K v , although K ATP and K ir channels are also present. 27, 28 Activation of these channels increases K + efflux, producing hyperpolarization of vascular smooth muscle. Therefore, the activity of these potassium channels plays an essential role in regulating membrane potential and vascular tone. 29 Moreover, changes in the expression and function of arterial K + channels have been observed in diseases such as hypertension, 30 and K + channel activators have proven to be clinically effective for the treatment of a variety of cardiovascular disorders. 31 In the present study, we pretreated aortic rings with several K + channel blockers to further test the hypothesis that warifteine induces vasorelaxation by activating K + channels. We found that the vasorelaxant effects of warifteine were modified by inhibition of BK Ca and K ATP channels. Furthermore, inhibition of K ir and K v channels had no effect on the concentration-response curve to warifteine. These findings indicate that the concentration-dependent relaxation elicited by warifteine involves activation of K + channels in the rat aorta.
The patch-clamp technique was used to gain further insight into the vascular effects of warifteine and to confirm the stimulatory effect of warifteine on K + channels. Warifteine, at concentrations that relaxed the rat aorta, increased K + currents recorded in single smooth muscle cells isolated from the same preparations, reinforcing our hypothesis that activation of K + current contributes to warifteine-induced relaxation. However, additional studies are needed to completely clarify the molecular events underlying K + current activation. Nevertheless, it is possible that BK Ca channels are preferentially activated by warifteine due to the significant increase in K + current only between 60 and 70 mV in cells dialysed with a pipette solution containing 5 mmol/L EGTA. The BK Ca channels are classically opened by a combination of membrane depolarization and elevated cytosolic Ca 2+ concentrations. 32 Under conditions that do not alter the concentration of intracellular Ca 2+ , these channels can be activated through increasing depolarization steps, as demonstrated by Mistry and Garland. 33 Previous studies have demonstrated that when physiological levels of intracellular Ca 2+ are maintained, the maximum current through BK Ca channels occurs between 60 and 80 mV. However, the increase in Ca 2+ concentration during inside-out studies clearly demonstrates that when varying the Ca 2+ concentration, the maximum membrane potential current reached is between 0 and 10 mV. 33 Under conditions of low cytosolic Ca 2+ concentrations, as used in the present study, we speculate that warifteine alters K + channel conductance, potentially through BK Ca channel activity and principally in the voltage range at which warifteine demonstrated stimulatory actions on K + currents.
We also investigated whether warifteine-induced vasorelaxation was related to the direct inhibition of Ca 2+ influx through VDCC channels, independent of K + channel opening. In high-K + (60 mmol/L), nominally Ca 2+ -free Krebs' solution, contractions were evoked by the cumulative addition of CaCl 2 . It is important to note that this medium has a high K + concentration, which is known to reduce the electrochemical gradient for K + efflux and to negatively affect the vasorelaxation effect related to K + channel activation. Thus, it was possible to assess the direct effect of warifteine on Ca 2+ influx, independent of hyperpolarization. Our results indicate that warifteine does not produce a significant change in Ca 2+ influx under these conditions.
Together, our results support the hypothesis that the actions of warifteine include increasing the open probability of K + channels but that warifteine is not an active Ca 2+ channel blocker in the rat aorta.
Warifteine-mediated vasorelaxation was initially demonstrated in rabbit aorta. 12 However, the mechanisms observed in the present study are distinct from those described earlier in rabbit aortic preparations, in which inhibition of voltage-gated Ca 2+ channels appeared to be the principal underlying mechanism. These differences may be explained by the unique responses observed in different animal species. It is evident that the pharmacological characteristics are not uniform between different vascular beds or even between the same vessels from different species. 34 There are substantial differences in the degree of innervations, 35 the use of intracellular and extracellular calcium for contractions 36, 37 and in receptor expression profiles. [38] [39] [40] In conclusion, the present study provides experimental evidence for a key mechanism by which warifteine relaxes the rat aorta, which increases the understanding as to how warifteine and other related bisbenzylisoquinoline alkaloids mediate vasorelaxation in vitro. The findings of the present study strongly suggest that the vasorelaxant effects of warifteine may be due to changes in the open probability of K + channels.
